Memorial Sloan Kettering Cancer Center - Nassau is a clinical research site located in Uniondale, New York, United States 11553.
Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.
Memorial Sloan Kettering Cancer Center - Nassau has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Renal Cell Carcinoma, Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations, Carcinoma, Transitional Cell.
Sponsors: AVEO Pharmaceuticals, Inc., Taiho Oncology, Inc., Astellas Pharma Global Development, Inc..
Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Memorial Sloan Kettering Cancer Center - Nassau has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memorial Sloan Kettering Cancer Center - Nassau has 3 clinical trials on record, with 2 currently active. Their work covers Renal Cell Carcinoma, Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations, Carcinoma, Transitional Cell.
Memorial Sloan Kettering Cancer Center - Nassau has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.